CLINICAL ASSESSMENT OF THE PERORAL METOPIRONE TEST.
D000236:Adenoma; D000238:Adenoma, Chromophobe; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone; D003480:Cushing Syndrome; D003920:Diabetes Mellitus; D003922:Diabetes Mellitus, Type 1; D004358:Drug Therapy; D006801:Humans; D007016:Hypophysectomy; D007018:Hypopituitarism; D007659:Ketones; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010912:Pituitary-Adrenal Function Tests; D014116:Toxicology; D014556:Urine
D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
ADENOMA, CHROMOPHOBE; ADRENALECTOMY; ALDOSTERONE ANTAGONISTS; CORTICOTROPIN; CUSHING'S SYNDROME; DIABETES MELLITUS, JUVENILE; DRUG THERAPY; HYPOPHYSECTOMY; HYPOPITUITARISM; KETONES; METYRAPONE; PITUITARY-ADRENAL FUNCTION TESTS; TOXICOLOGIC REPORT; URINE